20135 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS
#2Dietary Pattern Directed Nutritional Supplementation Composition and Methods for Attenuating Age-Related Cognitive Decline or Enhancing Cognitive Function
#3PHARMACEUTICAL COMPOSITION COMPRISING ROSUVASTATIN AND ACETYLSALICYLIC ACID, PROCESS FOR PREPARING THE SAME, AND USES THEREOF
#4Self-Emulsifying Systems For Cannabinoids
#5METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
#6METHOD OF TREATING AN ACUTE OR CHRONIC RESPIRATORY DISEASE IN A MAMMALIAN SUBJECT
#7PHARMACEUTICAL COMPOSITIONS OF TRETINOIN AND METHODS OF PRODUCING SUCH COMPOSITIONS
#8SOLID DOSAGE FORM OF A SMALL MOLECULE ANTIVIRAL AND USES THEREOF
#9USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME
#10STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#11RECEPTACLE, DEVICE FOR RELEASING CARBON MONOXIDE, TREATMENT SYSTEM, SET FOR TREATING LIVING CELLS, METHOD OF TREATING A MAMMAL, AND CARBON MONOXIDE
#12LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#13MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
#14Compositions for Treatment of Attention Deficit Hyperactivity Disorder
#15Orally Administrable Pharmaceutical Dosage Form Comprising Lanthanum and Its Use in a Method Of Treatment of Hyperoxaluria
#16METHODS OF TREATING MULTIPLE SCLEROSIS
#17NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
#18NON-DIGESTIBLE CAPSULES FOR THE DELIVERY OF FLUID ABSORBING MATERIALS
#19COMBINATION FORMULATION OF CEDAZURIDINE
#20Methods and Compositions for Treating Diabetes
#21PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
#22TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT
#23CAPSULE FORMULATIONS
#24SOFT DUAL CHAMBERED LIQUID-GEL CAPSULE AND METHOD TO DELIVER SUBLINGUAL AND INGESTIBLE CANNABIS COMPOSITIONS
#25Structured solid dosage form
#26FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
#27COMPOSITIONS FOR TREATING ADDICTION
#28PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
#29COVALENTLY CROSSLINKED POLYSACCHARIDES AND METHODS OF USE THEREOF
#30PIPERIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#31USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN
#32PHARMACEUTICAL FORMULATION
#33MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
#34COMPOSITIONS FOR INHIBITING ANAEROBIC MICROORGANISMS
#35MULTICOMPONENT CAPSULES
#36TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT
#37DEVICES AND METHODS TO IMPROVE BIOAVAILABILITY OF THERAPEUTIC AGENTS
#38DRUG DELIVERY SYSTEM COMPRISING MONOMETHYL FUMARATE
#39PHARMACEUTICAL COMPOSITION COMPRISING ACETYLSALICYLIC ACID AND PROTON PUMP INHIBITOR
#40IONIC LIQUID SALTS OF ACTIVE PHARMACEUTICAL INGREDIENTS
#41Degradable device for the passive and traceable release of a substance
#42PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF
#43DIETARY NUTRIENT COMPOSITIONS
#44PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD
#45PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#46IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING BUPROPION FOR WEIGHT LOSS
#47IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS INCLUDING NALTREXONE FOR WEIGHT LOSS
#48IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS
#49SUSTAINED RELEASE COMPOSITION COMPRISING A METHYLCELLULOSE
#50USTEKINUMAB DOSAGE FORMS AND METHODS
#51NEW DELAYED RELEASE COMPOSITION FOR PERORAL ADMINISTRATION
#52PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS
#53HARD CAPSULE INCLUDING MULTIPLE LOCKING PARTS
#54ANANDAMIDE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES
#55COMPOSITIONS AND METHODS FOR PROMOTING A HEALTHY MICROBIAL FLORA IN A MAMMAL
#56DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF
#57DIE ROLL FOR FORMING SOFT GEL CAPSULES
#58METHOD OF TREATMENT OF PARKINSON’S DISEASE
#59PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES
#60COMPOSITION CONTAINING LIPOSOMES AND BIOSURFACTANTS
#61DEVICE, SYSTEM AND METHODS FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS
#62MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
#63Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
#64Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof
#65SWALLOWABLE, SELF-EXPANDABLE DRUG DELIVERY DEVICE AND USES THEREOF
#66MEDICAL DEVICES AND IMPLEMENTS WITH LIQUID-IMPREGNATED SURFACES
#67COLON LAVAGE SYSTEM
#68Delayed Release Compositions of Linaclotide
#69DRUG DELIVERY VEHICLES, METHODS OF PRODUCING DRUG DELIVERY VEHICLES, AND METHODS OF USING DRUG DELIVERY VEHICLES
#70DRUG DELIVERY SYSTEM COMPRISING MONOMETHYL FUMARATE
#71ORAL DOSAGE FORM WITH IONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT
#72Monomethylfumarate Prodrug Compositions
#73METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS
#74MICROCAPSULE DISPERSIONS WITH EMULSIFIER
#75Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
#76Preparation Method for Nutritional Gummies Containing High-loading Liquid Capsules
#77Crystal Modifications of Odevixibat
#78Probiotic Delivery Systems
#79SWALLOWABLE DRUG DELIVERY DEVICE AND METHODS OF DRUG DELIVERY
#80Compositions for inhibiting anaerobic microorganisms
#81Cannabinoid Self-Emulsifying Systems
#82INSTANT RELEASE PHARMACEUTICAL PREPARATION OF ANTICOAGULANT AND PREPARATION METHOD THEREFOR
#83DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
#84PHARMACEUTICAL FORMULATION
#85OPIOID OVERDOSE RESCUE DEVICE
#86STABLE CAPSULES WITH FECAL MICROBIOTA OR A CULTURE OF MICROORGANISMS
#87Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
#88USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME
#89DRUG DELIVERY DEVICE WITH CAPSULE LOCK
#90LACTOBACILLUS PLANTARUM ZUST49 AND BACTERIAL AGENT, AND USE THEREOF
#91TARGETED GASTROINTESTINAL TRACT DELIVERY OF PROBIOTIC ORGANISMS AND/OR THERAPEUTIC AGENTS
#92ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS
#93Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#94INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS
#95HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING
#96MICROMOTORS AND NANOMOTORS FOR GASTROINTESTINAL DIAGNOSIS AND TREATMENT APPLICATIONS
#97Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#98Orally Ingestible Delivery System
#99INGESTIBLE DEVICE
#100INGESTIBLE DEVICES, SYSTEMS, AND METHODS THEREOF FOR GASTROINTESTINAL APPLICATIONS
#101PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI
#102Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule
#103Self-Emulsifying Systems For Cannabinoids
#104SOLID SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS
#105COMPOSITIONS, DEVICES AND METHODS FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES
#106DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME
#107Methods and Compositions for Treating Diabetes
#108METHODS OF PROBIOTIC TREATMENT TO IMPROVE HUMAN HEALTH
#109METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS
#110CAPSULE FORMULATIONS
#111PHARMACEUTICALLY STABLE SOFT CAPSULE COMPRISING TWO OR MORE DIFFERENT COMPOSITIONS
#112Method to Control Administration of Active Substance to the Digestive Tract
#113PROGESTOGEN FORMULATIONS FOR USE IN MODULATING A CYTOKINE STORM MEDIATOR
#114INGESTIBLE DEVICE FOR DELIVERY OF THERAPEUTIC AGENT TO THE GASTROINTESTINAL TRACT
#115Pharmaceutical Formulations Containing Relacorilant, a Heteroaryl-Ketone Fused Azadecalin Compound
#116SAFE USE OF MMP-12 INHIBITOR
#117Microbiome protection from oral antibiotics
#118NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION
#119FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
#120PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#121Compositions for Treatment of Attention Deficit Hyperactivity Disorder
#122DRUG DELIVERY IN NEGATIVE POISSON`S RATIO STRUCTURES
#123COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#124TWO-COMPONENT COMPOSITION
#125CYCLIC PHOSPHONATE COMPOSITION AND PREPARATION METHOD THEREOF
#126USE OF A COMBINATION OF SACUBITRIL AND VALSARTAN
#127CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR
#128METHODS FOR IN VIVO DELIVERY OF MICROBES TO HUMAN MICROENVIRONMENTS
#129IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
#130INDIVIDUAL DOSING OF CANNABIS AND TOBACCO FOR STANDARDIZATION AND CONTROL
#131Pharmaceutical composition and administrations thereof
#132TRANSDERMAL VACCINE
#133LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION
#134Orally available articles containing at least one stabilized supplement therein
#135DRUG DELIVERY IN NEGATIVE POISSON`S RATIO STRUCTURES
#136PROCESS OF MAKING STABLE ABUSE-DETERRENT ORAL FORMULATIONS
#137MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM FOR ORAL ADMINISTRATION
#138COAXIAL NOZZLE CONFIGURATION AND METHODS THEREOF
#139Treatment of Constipation-Predominant Irritable Bowel Syndrome
#140DHA and Choline Emulsion
#141THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#142METHOD OF DELIVERING A SOMATOSTATIN COMPOUND INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#143PROBIOTIC MICROCAPSULE AND PREPARATION METHOD THEREOF
#144Self-emulsifying cannabidiol formulations
#145PHARMACEUTICAL FORMULATION OF ODEVIXIBAT
#146FORMULATIONS COMPRISING CYCLOSPORIN A
#147Device, system and methods for the oral delivery of therapeutic compounds
#148SUSTAINED RELEASE FORMULATIONS OF CRYSTALLINE DRUGS
#149METHODS AND COMPOSITIONS FOR PRECISION RELEASE OF PROBIOTICS TO IMPROVE HUMAN HEALTH
#150Low-Dose Stable Formulations of Linaclotide
#151Immediate and controlled release appetite suppressant compositions for weight loss
#152FABRICATION OF TEXTILE-BASED CAPSULES
#153MICROPARTICLES CONTAINING STABILIZED CBD OIL, AND METHODS FOR THE PRODUCTION THEREOF
#154CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT
#155TREATMENTS FOR HEMOPHILIA A
#156SEALING FLUID FOR SEALING CAPSULES
#157PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
#158Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
#159SELF-ACTUATING ARTICLES
#160ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A METHYL HYDROGEN FUMARATE PRODRUG
#161THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#162Medical devices and implements with liquid-impregnated surfaces
#163DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF
#164NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS
#165PROCESS FOR THE PREPARATION OF BRIVARACETAM
#166SYSTEM, METHOD, DEVICE, AND COMPOUND FOR FACILITATING MULTICOMPARTMENT CAPSULES
#167PREPARATION COMPRISING EXANATIDE FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT
#168ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS
#169Delayed Release Compositions of Linaclotide
#170DRUG DOSAGE FORMS FOR STOMACH RETENTION
#171GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM
#172Granular Pharmaceutical Composition
#173OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
#174Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and use
#175THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#176MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE
#177Delayed release composition for peroral administration
#178SOLID DOSAGE FORMS CONTAINING BACTERIA AND MICROBIAL EXTRACELLULAR VESICLES
#179BIODEGRADABLE POLYCAPROLACTONE CAPSULE FOR ANTIBODY RELEASE AND DEGRADATION
#180ORAL DRUG DELIVERY DEVICE WITH EXPANDING BAND
#181SUBSTANCE DELIVERING CAPSULE
#182ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS
#183PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
#184USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDER
#185THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#186Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#187IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
#188GREEN TEA FLOWER FORMULATION FOR WEIGHT MANAGEMENT
#189Compositions and methods for treating metabolic disorders
#190COMPOSITIONS AND METHODS TO PROMOTE BRAIN HEALTH
#191TARGETED GASTROINTESTINAL TRACT DELIVERY OF PROBIOTIC ORGANISMS AND/OR THERAPEUTIC AGENTS
#192Microbiome protection from oral antibiotics
#193Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy
#194Treatment of Constipation-Predominant Irritable Bowel Syndrome
#195Compositions and methods for treating centrally mediated nausea and vomiting
#196Oral Medicine Delivery Capsule
#197INGESTIBLE DEVICE HAVING A SPIKE ASSEMBLY
#198COMPOSITIONS, DEVICES AND METHODS FOR INDUCING IMMUNE RESPONSES TO INFECTIOUS AGENTS
#199ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMOD
#200METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD
#201PHARMACEUTICAL FORMULATION OF PALBOCICLIB AND A PREPARATION METHOD THEREOF
#202LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#203Self-righting systems, methods, and related components
#204Compositions and methods for treating eosinophilic disorders
#205METHODS AND COMPOSITIONS FOR TREATING DIABETES
#206CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED DRUG DELIVERY
#207THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#208SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES
#209Methods for inhibiting anaerobic microorganisms
#210Compositions for inhibiting anaerobic microorganisms
#211IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
#212Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
#213DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#214Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
#215Delayed Release Compositions of Linaclotide
#216Compounds to Modulate Intestinal Absorption of Nutrients
#217Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
#218PHARMACEUTICAL FORMULATION
#219GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#220COMPOSITION COMPRISING A METAL ASCORBO-CAMPHORATE COMPOUND AND METHOD FOR PREVENTION AND/OR TREATMENT OF PAPILLOMAVIRUS INFECTIONS
#221Sublingual Delivery for Mitigation of Side Effects Associated with Zicronapine
#222Granular Pharmaceutical Composition
#223Die roll for forming soft gel capsules
#224Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#225Capsules with opacifier
#226Pharmaceutical compositions of mifepristone
#227PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
#228METHOD FOR TREATMENT OF ROSACEA IN PATIENTS AGED 35-64 YEARS
#229Methods for manufacturing capsules with ingestible event markers
#230FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
#231Method To Improve The Health Of The Microbiome In A Human Gastrointestinal System And Multi-Chamber Probiotic Delivery Products Therefor
#232Pharmaceutical formulation
#233PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND BACTERIOPHAGE APPLICATION DEVICE
#234Methotrexate Dosage Form
#235BIODEGRADABLE MICROCAPSULES
#236Self-righting systems and related components and methods
#237MAGNETIC MINIATURE DEVICE AND SYSTEM FOR REMOTELY MANEUVERING IT
#238ANTI-METHANOGENIC COMPOSITIONS AND USES THEREOF
#239INGESTIBLE DEVICE WITH PHARMACEUTICAL PRODUCT
#240Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
#241IMPLANTABLE MEDICAL DEVICES FOR EXTENDED RELEASE OF THERAPEUTIC AGENTS
#242SUSTAINED RELEASE DRUG DELIVERY DEVICE
#243Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
#244INGESTIBLE MEDICAL DELIVERY DEVICES
#245SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE
#246PRESSURIZED NUTRITIONAL SUPPLEMENT DELIVERY
#247PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD
#248PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER
#249Compartmented hard shell capsule and apparatus and method for forming, filling, and encapsulating a compartmented hard shell capsule
#250Pharmaceutical Composition Comprising Quinazoline Derivative or Salt Thereof
#251Method for treating coronavirus infections
#252PHARMACEUTICAL COMPOSITION COMPRISING PDE9 INHIBITOR
#253Method and Composition for Increasing Muscle Protein Synthesis
#254DIMETHYL FUMARATE PARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#255Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
#256Sustained Release Formulation Containing Aspalathus linearis Extract
#257Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates
#258TARGETED CHEMICAL DELIVERY CAPSULE
#259METHODS FOR DELIVERING ETANERCEPT PREPARATIONS INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#260PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#261Swallowable drug delivery device and methods of drug delivery
#262COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#263Dietary nutrient compositions
#264Compositions and methods for promoting a healthy microbial flora in a mammal
#265Pharmaceutical compositions for delivery of peptide
#266PHARMACEUTICAL PREPARATION
#267Crystal modifications of odevixibat
#268Components with high API loading
#269STABLE LOW DIGESTIVE ENZYME CONTENT FORMULATION
#270CAPSULE DEVICE HAVING IMPROVED SELF-RIGHTING ABILITY
#271Self-actuating articles
#272Granular Pharmaceutical Composition
#273MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#274COMPOSITION FOR TREATING OR PREVENTING MILD COGNITIVE IMPAIRMENT
#275Appetite suppressant compositions and methods thereof
#276Pharmaceutical composition and administrations thereof
#277Capsule formulations
#278MINI SOFTGEL NAPROXEN COMPOSITION
#279DIETARY NUTRIENT COMPOSITIONS
#280Two-component composition
#281COMPOSITION FOR TREATING OPIOID WITHDRAWAL AND METHOD OF MANUFACTURE
#282DOSING SYSTEM FOR CONTROLLED SUBSTANCES RELEASE BY MEANS OF DOSING MEMBRANES
#283COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#284CANNABINOID FORMULATIONS
#285Delayed release composition for peroral administration
#286Dry powder composition for peroral administration
#287Curcumin Solubilisate
#288THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#289Formulations of pimavanserin
#290THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#291SELF-RIGHTING ARTICLES
#292SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH METFORMIN
#293CAPSULE WITH INTERNAL DIAPHRAGM FOR IMPROVED BIOAVAILABILITY
#294Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy
#295METHOD FOR TREATMENT OF PARKINSON'S DISEASE
#296Biguanide compositions and methods of treating metabolic disorders
#297TISSUE ANCHORING ARTICLES
#298PHARMACEUTICAL DOSAGE FORM FOR APPLICATION TO MUCOUS MEMBRANES AND METHODS FOR PRODUCING SAME
#299LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION
#300METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES